Pharmaceuticals
France defines medical situations in which physicians can exclude generic substitution
07 January 2020 - Posted by: Eveline Van Keymeulen
On 19 November 2019, pursuant to Article 66 of the 2019 Social Security Financing Act (LFSS), the implementing order that indicates the medical situations in which physicians may exclude substitution on prescriptions was published (Order of 12 November 2019). For background information, see our previous blog post French 2019 Social Security Financing Act introduces new › Read More
Life Sciences and healthcare growth in more challenging times
03 January 2020 - Posted by: Matthew Appleton
At a time of heightened regulatory and market uncertainty, it’s perhaps surprising to see life sciences and healthcare sector M&A continuing to grow so strongly. Indeed, with deal value up by more than 19%, it was one of only two sectors to record growth in transaction value. Not surprisingly, given the scale of the U.S. › Read More
Dutch Minister of Care announces mandatory “base stocks” to prevent medicine shortages
20 December 2019 - Posted by: Sophie van Asten
On 4 November 2019, the Dutch Minister of Care wrote a letter to the House of Representatives, proposing a solution for medicine shortages. In order to prevent shortages, additional stocks of medicines should be built up by obliging medicine manufacturers and wholesalers to build up mandatory buffers (“base stocks”) of five months’ duration, starting in › Read More
CJEU: cannabis trade mark is contrary to public policy
12 December 2019 - Posted by: Beverley Potts
An application for the above trade mark covering food and beverage items has been rejected by the EU General Court. The court confirmed the EUIPO’s previous decision that the mark is contrary to public policy for the following reasons: The sign contains a stylised depiction of the cannabis plant, which is the media symbol for › Read More
French Administrative Supreme Court paves way for medical practitioner advertising
04 December 2019 - pharmaceuticals , Regulatory - Posted by: Eveline Van Keymeulen
On 6 November 2019, the French Council of State, the Administrative Supreme Court, granted the request to annul the implicit Minister of Health’s refusal to revoke the Articles of the Public Health Code (French language) that prohibited the use of any advertising by dentists and dental surgeons (Decision of 6 November 2019 docket 420225) (French › Read More